{"id":"comparator-fluticasone","safety":{"commonSideEffects":[{"rate":"5-10","effect":"Oropharyngeal candidiasis"},{"rate":"1-3","effect":"Tremor"},{"rate":"5-10","effect":"Headache"},{"rate":"1-5","effect":"Dysphonia"},{"rate":"1-3","effect":"Palpitations"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Fluticasone propionate is a potent inhaled corticosteroid that works by binding to intracellular glucocorticoid receptors in airway tissues, leading to decreased production of inflammatory cytokines, reduced recruitment of eosinophils and other immune cells, and decreased mucus production. This results in reduced airway inflammation, bronchial hyperresponsiveness, and airway remodeling in respiratory conditions.","oneSentence":"Fluticasone is a corticosteroid that reduces inflammation by binding to glucocorticoid receptors and suppressing immune cell activation and inflammatory mediator release.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:07:01.125Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Asthma maintenance therapy"},{"name":"Chronic obstructive pulmonary disease (COPD)"}]},"trialDetails":[{"nctId":"NCT05776927","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.","status":"NOT_YET_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2026-05-29","conditions":"Asthma","enrollment":304},{"nctId":"NCT07318350","phase":"PHASE3","title":"Study of Formoterol 6 mcg/Fluticasone 125 mcg by Eurofarma Laboratórios S.A. Versus Alenia® 6 mcg/200 mcg in Patients With Asthma (FORASMA)","status":"NOT_YET_RECRUITING","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2026-10","conditions":"Moderate Asthma","enrollment":174},{"nctId":"NCT05735431","phase":"PHASE3","title":"Non-Inferiority,Combination Formoterol/FluticasonexAlenia®Formoterol/Budesonide for Asthma in Brazil","status":"WITHDRAWN","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2026-06","conditions":"Moderate Asthma","enrollment":""},{"nctId":"NCT04885530","phase":"PHASE3","title":"ACTIV-6: COVID-19 Study of Repurposed Medications","status":"COMPLETED","sponsor":"Susanna Naggie, MD","startDate":"2021-06-08","conditions":"Covid19","enrollment":10956},{"nctId":"NCT06272370","phase":"PHASE4","title":"Individualizing Treatment for Asthma in Primary Care","status":"COMPLETED","sponsor":"DARTNet Institute","startDate":"2024-02-01","conditions":"Asthma, Bronchial Diseases, Respiratory Tract Infections","enrollment":103},{"nctId":"NCT06234345","phase":"PHASE3","title":"Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR)","status":"NOT_YET_RECRUITING","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2026-09","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":1252},{"nctId":"NCT00545324","phase":"PHASE4","title":"First Step With Singulair® Therapy (0476-323)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-09","conditions":"Asthma","enrollment":399},{"nctId":"NCT00489346","phase":"PHASE3","title":"A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-10","conditions":"Asthma, Bronchial","enrollment":994},{"nctId":"NCT00284856","phase":"PHASE3","title":"Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-05","conditions":"Asthma","enrollment":1640},{"nctId":"NCT05736874","phase":"PHASE3","title":"ACTIV-6: COVID-19 Study of Repurposed Medications - Arm C (Fluticasone)","status":"COMPLETED","sponsor":"Susanna Naggie, MD","startDate":"2021-08-06","conditions":"Covid19","enrollment":1407},{"nctId":"NCT02175771","phase":"PHASE3","title":"Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2014-07","conditions":"Persistent Asthma","enrollment":758},{"nctId":"NCT02680561","phase":"PHASE1","title":"A Double Blind Open Label Comparator Study to Compare Treatments in 4 to 11 Year Old Patients With Asthma","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2016-04","conditions":"Asthma","enrollment":20},{"nctId":"NCT01738087","phase":"PHASE2","title":"Lung Bioavailability and Total Systemic Exposure to Beclomethasone17MonoPropionate and Formoterol Across Two Strengths of NEXThaler Inhalation Powder","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2012-11","conditions":"Asthmatic","enrollment":30},{"nctId":"NCT01578278","phase":"PHASE2","title":"Bepotastine Besilate-corticosteroid Nasal Spray Combination Compared to Placebo, Bepotastine Besilate Nasal Spray, and Corticosteroid Nasal Spray in the Treatment of Patients With Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2011-12","conditions":"Seasonal Allergic Rhinitis","enrollment":606},{"nctId":"NCT03394989","phase":"PHASE3","title":"BE Study of Fluticasone Propionate/Salmeterol Inhalation Powder in Asthma Patients","status":"COMPLETED","sponsor":"Cipla Ltd.","startDate":"2018-10-17","conditions":"Bronchial Asthma","enrollment":1366},{"nctId":"NCT03898466","phase":"PHASE4","title":"Effect of Fluticasone Furoate on Methacholine Challenge","status":"COMPLETED","sponsor":"University of Saskatchewan","startDate":"2018-10-30","conditions":"Asthma","enrollment":14},{"nctId":"NCT01662778","phase":"PHASE4","title":"The Clinical Effect of Monodisperse Fluticasone Propionate in Asthma","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2011-12","conditions":"Asthma","enrollment":21},{"nctId":"NCT01424397","phase":"PHASE2","title":"Intranasal SB-705498 in Allergic Rhinitis (AR) Patients","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-04-14","conditions":"Rhinitis","enrollment":70},{"nctId":"NCT01400906","phase":"PHASE2","title":"Inhalation of Corticosteroids in Smoking and Non-smoking Asthmatics.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-07-20","conditions":"Asthma","enrollment":36},{"nctId":"NCT01475721","phase":"PHASE4","title":"SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-11-18","conditions":"Asthma","enrollment":11751},{"nctId":"NCT01313676","phase":"PHASE3","title":"Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-01-25","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":16568},{"nctId":"NCT01916226","phase":"PHASE4","title":"A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-08-01","conditions":"Rhinitis, Allergic, Perennial and Seasonal","enrollment":682},{"nctId":"NCT00695604","phase":"PHASE2","title":"Repeated High-dose Inhaled Corticosteroids for Asthma","status":"WITHDRAWN","sponsor":"University of Chicago","startDate":"2008-05","conditions":"Asthma","enrollment":""},{"nctId":"NCT00603382","phase":"PHASE2","title":"A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Non-steroidal Therapy.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-12-01","conditions":"Asthma","enrollment":599},{"nctId":"NCT01018186","phase":"PHASE3","title":"Fluticasone Furoate/GW642444 Inhalation Powder Long-Term Safety Study","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-10-19","conditions":"Asthma","enrollment":503},{"nctId":"NCT00214019","phase":"NA","title":"The Effect of Salmeterol on Eosinophil (EOS) Function","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2003-11","conditions":"Allergic Asthma","enrollment":36},{"nctId":"NCT01124422","phase":"PHASE4","title":"Fluticasone Propionate/Salmeterol Combination 250/50 DISKUS in the Exercise Endurance Time in Patients With Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-07-19","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":255},{"nctId":"NCT01147744","phase":"PHASE2","title":"Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-06-28","conditions":"Asthma","enrollment":700},{"nctId":"NCT00642148","phase":"PHASE2","title":"A 12 Week Study To Assess Efficacy And Safety Of GW856553 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-02-14","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":306},{"nctId":"NCT01772368","phase":"PHASE2","title":"Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2013-01","conditions":"Asthma","enrollment":72},{"nctId":"NCT00197106","phase":"PHASE4","title":"Treatment Of Symptomatic Asthma In Children","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-06","conditions":"Asthma","enrollment":176},{"nctId":"NCT01498679","phase":"PHASE3","title":"Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2012-01","conditions":"Asthma","enrollment":311},{"nctId":"NCT00503009","phase":"PHASE4","title":"Study Of RV-39 In Patients Who Also Have Asthma","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2007-10","conditions":"Asthma","enrollment":16},{"nctId":"NCT00539006","phase":"PHASE4","title":"Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-08","conditions":"Rhinitis, Allergic, Perennial","enrollment":377},{"nctId":"NCT00519636","phase":"PHASE4","title":"Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-08","conditions":"Rhinitis, Allergic, Perennial","enrollment":360},{"nctId":"NCT00387036","phase":"PHASE2","title":"Exercise Study in Patient With Chronic Obstructive Pulmonary Disease (0000-036)","status":"TERMINATED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2006-12","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":12},{"nctId":"NCT02403713","phase":"PHASE1","title":"A Pharmacokinetic/Pharmacodynamic Inhaler Comparison Study in Healthy Volunteers","status":"COMPLETED","sponsor":"Mundipharma Research Limited","startDate":"2014-08","conditions":"Asthma","enrollment":125},{"nctId":"NCT00869596","phase":"PHASE1","title":"Study of Biomarkers of Airway Inflammation (0000-128)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2009-03","conditions":"Airway Inflammation","enrollment":22},{"nctId":"NCT00623714","phase":"PHASE1","title":"Induced Sputum Study (0000-065)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2008-01","conditions":"Asthma","enrollment":13},{"nctId":"NCT00456313","phase":"PHASE4","title":"No Resistance After Long Term Treatment SERETIDE","status":"WITHDRAWN","sponsor":"GlaxoSmithKline","startDate":"2007-12","conditions":"Asthma","enrollment":""},{"nctId":"NCT01709903","phase":"PHASE3","title":"A 26-week Treatment Randomized, Double-blind, Double Dummy Study to Assess the Efficacy and Safety of QVA149","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2012-11","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":744},{"nctId":"NCT02279563","phase":"PHASE2","title":"A Study Comparing the Bioequivalence of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Apotex, Inc.) to That of Dymista™ Nasal Spray (Meda Pharmaceuticals, Inc.) in the Treatment of Seasonal Allergic Rhinitis","status":"UNKNOWN","sponsor":"Apotex Inc.","startDate":"2013-12","conditions":"Seasonal Allergic Rhinitis","enrollment":595},{"nctId":"NCT00527826","phase":"PHASE4","title":"Influence Of Salmeterol Xinafoate/Fluticasone Propionate (50/500 µg BID) On The Course Of The Disease And Exacerbation Frequency In COPD Patients Gold Stage III And IV","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-11","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":214},{"nctId":"NCT00848965","phase":"PHASE4","title":"A Randomised, Double Blind, Placebo Controlled, 4 Period, Incomplete Block, Crossover Study Assessing the Dose-response Curve of Fluticasone Propionate in an Antigen Challenge Chamber","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-10","conditions":"Rhinitis, Allergic, Perennial, Allergic Rhinitis","enrollment":59},{"nctId":"NCT00656916","phase":"PHASE2","title":"Inhaled Corticosteroids Versus Observation for Patients With Decreased Lung Function Status","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2008-03","conditions":"Bronchiolitis","enrollment":1},{"nctId":"NCT00655616","phase":"NA","title":"Add-on Salmeterol Versus Montelukast in Arg/Arg-16 Asthmatics","status":"COMPLETED","sponsor":"University of Dundee","startDate":"2007-08","conditions":"Asthma","enrollment":64},{"nctId":"NCT00641680","phase":"PHASE3","title":"Rhinocort Aqua Versus Placebo and Fluticasone Propionate","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2003-04","conditions":"Seasonal Allergic Rhinitis","enrollment":750},{"nctId":"NCT00280358","phase":"PHASE1","title":"A Study in Healthy Volunteers to Evaluate Serum and Urine Levels of the Investigational Product Versus Comparator.","status":"COMPLETED","sponsor":"Dey","startDate":"","conditions":"Healthy","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2510,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["fluticasone"],"phase":"phase_3","status":"active","brandName":"Comparator: fluticasone","genericName":"Comparator: fluticasone","companyName":"Merck Sharp & Dohme LLC","companyId":"merck","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Fluticasone is a corticosteroid that reduces inflammation by binding to glucocorticoid receptors and suppressing immune cell activation and inflammatory mediator release. Used for Asthma maintenance therapy, Chronic obstructive pulmonary disease (COPD).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}